OriCell Therapeutics invites Professor Gao Shaorong, Dean of School of Life Sciences and Technology and Assistant Dean of Institute for Advanced Study in Translational Medicine, Tongji University, as the chief expert. In the next three years, we will actively carry out research and clinical transformation of products targeting key challenges in tumor immunotherapy through the development of new technologies, so as to break through the technical bottlenecks that currently restrict the development of enterprises and the industry field, eventually producing low-cost and effective cell therapy products against tumor with great application potential. The two parties will also jointly cultivate a team of compound professionals including postdoctoral, doctoral and master's degree holders in the development and transformation of tumor-targeting immunotherapy technologies and products to achieve rapid transformation of scientific research achievements.